Kineret — CareFirst (Caremark)
Immune checkpoint inhibitor-related toxicity
Initial criteria
- Member has immunotherapy-related hemophagocytic lymphohistiocytosis (HLH)-like syndrome.
- Member has had an inadequate response to systemic corticosteroids OR has an intolerance or contraindication to corticosteroids.
Approval duration
6 months